A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 21 Aug 2017
At a glance
- Drugs Semaglutide (Primary) ; Furosemide; Rosuvastatin; Salcaprozate sodium
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 15 Aug 2017 Status changed from active, no longer recruiting to completed.
- 24 May 2017 Planned End Date changed from 23 Jun 2017 to 15 Jul 2017.
- 26 Apr 2017 Status changed from recruiting to active, no longer recruiting.